<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>41</viewCount><searchCount>0</searchCount></scores><additional><submitter>Takemiya K</submitter><funding>American Heart Association</funding><funding>NIBIB NIH HHS</funding><funding>American Heart Association-American Stroke Association</funding><funding>National Institute of Biomedical Imaging and Bioengineering</funding><pagination>e0247673</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7920357</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(3)</volume><pubmed_abstract>Infectious endocarditis is a life-threatening disease, and diagnostics are urgently needed to accurately diagnose this disease especially in the case of prosthetic valve endocarditis. We show here that maltohexaose conjugated to indocyanine green (MH-ICG) can detect Staphylococcus aureus (S. aureus) infection in a rat model of infective endocarditis. The affinity of MH-ICG to S. aureus was determined and had a Km and Vmax of 5.4 μM and 3.0 X 10-6 μmol/minutes/108 CFU, respectively. MH-ICG had no detectable toxicity to mammalian cells at concentrations as high as 100 μM. The in vivo efficiency of MH-ICG in rats was evaluated using a right heart endocarditis model, and the accumulation of MH-ICG in the bacterial vegetations was 2.5 ± 0.2 times higher than that in the control left ventricular wall. The biological half-life of MH-ICG in healthy rats was 14.0 ± 1.3 minutes, and approximately 50% of injected MH-ICG was excreted into the feces after 24 hours. These data demonstrate that MH-ICG was internalized by bacteria with high specificity and that MH-ICG specifically accumulated in bacterial vegetations in a rat model of endocarditis. These results demonstrate the potential efficacy of this agent in the detection of infective endocarditis.</pubmed_abstract><journal>PloS one</journal><pubmed_title>Maltohexaose-indocyanine green (MH-ICG) for near infrared imaging of endocarditis.</pubmed_title><pmcid>PMC7920357</pmcid><funding_grant_id>R01 EB029320</funding_grant_id><funding_grant_id>1R01EB029320-01A1</funding_grant_id><funding_grant_id>AHA-SDG 17SDG33410912</funding_grant_id><funding_grant_id>R01 EB020008</funding_grant_id><funding_grant_id>NIH1R01 EB020008-01A1</funding_grant_id><funding_grant_id>17SDG33410912</funding_grant_id><pubmed_authors>Rodriguez AG</pubmed_authors><pubmed_authors>Roise JJ</pubmed_authors><pubmed_authors>Taing C</pubmed_authors><pubmed_authors>Murthy N</pubmed_authors><pubmed_authors>Goodman MM</pubmed_authors><pubmed_authors>He M</pubmed_authors><pubmed_authors>Takemiya K</pubmed_authors><pubmed_authors>Taylor WR</pubmed_authors><view_count>41</view_count></additional><is_claimable>false</is_claimable><name>Maltohexaose-indocyanine green (MH-ICG) for near infrared imaging of endocarditis.</name><description>Infectious endocarditis is a life-threatening disease, and diagnostics are urgently needed to accurately diagnose this disease especially in the case of prosthetic valve endocarditis. We show here that maltohexaose conjugated to indocyanine green (MH-ICG) can detect Staphylococcus aureus (S. aureus) infection in a rat model of infective endocarditis. The affinity of MH-ICG to S. aureus was determined and had a Km and Vmax of 5.4 μM and 3.0 X 10-6 μmol/minutes/108 CFU, respectively. MH-ICG had no detectable toxicity to mammalian cells at concentrations as high as 100 μM. The in vivo efficiency of MH-ICG in rats was evaluated using a right heart endocarditis model, and the accumulation of MH-ICG in the bacterial vegetations was 2.5 ± 0.2 times higher than that in the control left ventricular wall. The biological half-life of MH-ICG in healthy rats was 14.0 ± 1.3 minutes, and approximately 50% of injected MH-ICG was excreted into the feces after 24 hours. These data demonstrate that MH-ICG was internalized by bacteria with high specificity and that MH-ICG specifically accumulated in bacterial vegetations in a rat model of endocarditis. These results demonstrate the potential efficacy of this agent in the detection of infective endocarditis.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2024-02-14T23:51:40.748Z</modification><creation>2021-03-13T08:14:28Z</creation></dates><accession>S-EPMC7920357</accession><cross_references><pubmed>33647027</pubmed><doi>10.1371/journal.pone.0247673</doi></cross_references></HashMap>